These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 713008)

  • 1. Metastatic non-oat-cell bronchogenic carcinoma. Therapy with cyclophosphamide, doxorubicin, methotrexate, and procarbazine (CAMP).
    Bitran JD; Desser RK; DeMeester T; Golomb HM
    JAMA; 1978 Dec; 240(25):2743-6. PubMed ID: 713008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclophosphamide, adriamycin, methotrexate, and procarbazine (CAMP)--effective four-drug combination chemotherapy for metastatic non-oat cell bronchogenic carcinoma.
    Bitran JD; Desser RK; DeMeester TR; Colman M; Evans R; Billings A; Griem M; Rubenstein L; Shapiro C; Golomb HM
    Cancer Treat Rep; 1976 Sep; 60(9):1225-30. PubMed ID: 189920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined radiotherapy and chemotherapy with cyclophosphamide, adriamycin, methotrexate, procarbazine (CAMP) in 64 consecutive patients with epidermoid bronchogenic carcinoma, limited disease: a prospective study.
    Trovò MG; Tirelli U; De Paoli A; Franchin G; Roncadin M; Magri M; Galligioni E; Veronesi A; Tumolo S; Carbone A; Grigoletto E
    Int J Radiat Oncol Biol Phys; 1982 Jun; 8(6):1051-4. PubMed ID: 7107434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. "CAMP" combination chemotherapy for unresectable non-oat cell bronchogenic carcinoma.
    Lad T; Sarma PR; Diekamp U; Tichler T; Chawla M; Krauss S; Zawila P; Nelson R
    Cancer Clin Trials; 1979; 2(4):321-6. PubMed ID: 394868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prognostic factors in the chemotherapy of bronchial cancers].
    Alberto P
    Schweiz Med Wochenschr; 1974 Feb; 104(8):268-71. PubMed ID: 4360755
    [No Abstract]   [Full Text] [Related]  

  • 6. Cyclophosphamide, adriamycin, methotrexate, and procarbazine (CAMP) treatment of non-oat cell bronchogenic carcinoma.
    Vogelzang NJ; Bonomi PD; Rossof AH; Wolter J
    Cancer Treat Rep; 1978 Oct; 62(10):1595-7. PubMed ID: 709563
    [No Abstract]   [Full Text] [Related]  

  • 7. CAMP chemotherapy for metastatic non-oat cell bronchogenic carcinoma. A 7-year experience (1975-1981) with 160 patients.
    Shepard KV; Golomb HM; Bitran JD; Hoffman PC; Newman SB; DeMeester TR; Skosey C
    Cancer; 1985 Nov; 56(10):2385-90. PubMed ID: 3876149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined modality therapy for stage IIIMO non-oat cell bronchogenic carcinoma.
    Bitran JD; Desser RK; DeMeester T; Shapiro CM; Billings A; Rubenstein L; Evans R; Colman M; Rao CY; Griem M; Golomb HM
    Cancer Treat Rep; 1978 Mar; 62(3):327-32. PubMed ID: 348305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of bronchogenic carcinoma with simultaneous or sequential combination chemotherapy, including methotrexate, cyclophosphamide, procarbazine and vincristine.
    Alberto P; Brunner KW; Martz G; Obrecht J; Sonntag RW
    Cancer; 1976 Dec; 38(6):2208-16. PubMed ID: 187313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemotherapy for bronchogenic carcinoma. Methotrexate, doxorubicin, cyclophosphamide, and lomustine.
    Chahinian PA; Arnold DJ; Cohen JM; Purpora DP; Jaffrey IS; Teirstein AS; Kirschner PA; Holland JF
    JAMA; 1977 May; 237(22):2392-6. PubMed ID: 576939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metastatic non-small cell bronchogenic carcinoma: a randomized trial of sequential vs combination chemotherapy.
    Hoffman PC; Newman SB; Golomb HM; Demeester TR; Blough RR; Sovik CA
    Eur J Cancer Clin Oncol; 1983 Jan; 19(1):33-8. PubMed ID: 6303793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemotherapy of lung cancer: the experience of the National Cancer Institute of Milan.
    Bonadonna G; Tancini G; Bajetta E
    Cancer Chemother Rep 3; 1973 Mar; 4(2):231-7. PubMed ID: 4125741
    [No Abstract]   [Full Text] [Related]  

  • 13. Chemotherapy for metastatic non-small cell bronchogenic carcinoma: EST 2575, generation III, HAM versus CAMP.
    Ruckdeschel JC; Mehta CR; Salazar OM; Creech RH; Sponzo RW
    Cancer Treat Rep; 1981; 65(11-12):959-63. PubMed ID: 6794909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Chemotherapy of the non-small cell bronchogenic carcinoma].
    Dimitriadis K; Boutis L; Tavantzis J; Mouratidou D; Bouchoris N; Koukourikos S; Hatzigogos K; Safarini S
    Onkologie; 1983 Feb; 6(1):8-10. PubMed ID: 6189039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hexamethylmelamine, bleomycin, and CCNU chemotherapy for patients with squamous cell carcinoma, large cell carcinoma, and adenocarcinoma of the lung unresponsive to cyclophosphamide, adriamycin, methotrexate, and procarbazine.
    Mintz U; Bitran JD; Cooksey JA; Desser RK; DeMeester TR; Golomb HM
    Cancer Treat Rep; 1978 Apr; 62(4):567-9. PubMed ID: 77725
    [No Abstract]   [Full Text] [Related]  

  • 16. Chemotherapy of extensive large cell and adenocarcinoma of the lung: a randomized trial in 210 patients.
    Vincent RG; Mehta CR; Tucker RD; Mountain CF; Cohen M; Wilson HE; Vogel C
    Cancer; 1980 Jul; 46(2):256-60. PubMed ID: 6992978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bleomycin (NSC-125066) followed by cyclophosphamide (NSC-26271), vincristine (NSC-67574), methotrexate (NSC-740), and 5-fllorouracil (NSC-19893) for non-oat cell bronchogenic carcinoma.
    Lanzotti VJ; Thomas DR; Holoye PY; Boyle LE; Smith TL; Samuels ML
    Cancer Treat Rep; 1976 Jan; 60(1):61-8. PubMed ID: 63331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination chemotherapy of bronchogenic carcinoma. I. Non-oat cell.
    Livingston RB
    Cancer Treat Rev; 1977 Sep; 4(3):153-65. PubMed ID: 73419
    [No Abstract]   [Full Text] [Related]  

  • 19. Six-drug combination chemotherapy for nonresectable bronchogenic carcinoma.
    Miller CF; Weltz MD; Heim WJ; Blom J
    Cancer Treat Rep; 1979 Aug; 63(8):1351-3. PubMed ID: 113094
    [No Abstract]   [Full Text] [Related]  

  • 20. CAMP (cyclophosphamide, doxorubicin, methotrexate, and procarbazine) for epidermoid and large cell anaplastic carcinoma of the lung.
    Cambareri RJ; Smith FP; Macdonald JS; Haidak DJ; Ueno WM; Hoth DH; Woolley PV; Schein PS
    Cancer Treat Rep; 1981; 65(3-4):317-20. PubMed ID: 6263471
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.